Barnett SW et al. |
Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. |
1997 |
Vaccine |
pmid:9234536
|
Hilgers LA et al. |
A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals. |
1994 |
Vaccine |
pmid:8085385
|
Hilgers LA et al. |
A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs. |
1994 |
Vaccine |
pmid:8085386
|
Heineman TC et al. |
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. |
1999 |
Vaccine |
pmid:10438046
|
Boyce TG et al. |
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. |
2000 |
Vaccine |
pmid:10930676
|
O'Hagan DT et al. |
Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. |
2000 |
Vaccine |
pmid:10699327
|
Black S et al. |
Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis. |
2010 |
Vaccine |
pmid:20813217
|
Cristiani C et al. |
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district. |
2011 |
Vaccine |
pmid:21396903
|
Meier S et al. |
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. |
2011 |
Vaccine |
pmid:21419775
|
Parretta E et al. |
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. |
2011 |
Vaccine |
pmid:21406267
|
Morel S et al. |
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. |
2011 |
Vaccine |
pmid:21256188
|
Decaro N et al. |
Immunogenicity and protective efficacy in dogs of an MF59â„¢-adjuvanted vaccine against recombinant canine/porcine coronavirus. |
2011 |
Vaccine |
pmid:21272607
|
Keitel W et al. |
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. |
2010 |
Vaccine |
pmid:19835829
|
Vesikari T et al. |
MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. |
2009 |
Vaccine |
pmid:19840662
|
Tsai T et al. |
Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. |
2010 |
Vaccine |
pmid:19969117
|
Pietrella D et al. |
A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. |
2010 |
Vaccine |
pmid:20038431
|
Della Cioppa G et al. |
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. |
2011 |
Vaccine |
pmid:21906647
|
Fox CB et al. |
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. |
2011 |
Vaccine |
pmid:21906648
|
de Bruijn I et al. |
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. |
2007 |
Vaccine |
pmid:18063446
|
Singh M et al. |
A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens. |
2006 |
Vaccine |
pmid:16300864
|
Puig-Barberà J et al. |
Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. |
2004 |
Vaccine |
pmid:15530669
|
Del Giudice G et al. |
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. |
2006 |
Vaccine |
pmid:16464520
|
Precioso AR et al. |
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. |
2011 |
Vaccine |
pmid:21945258
|
Pariani E et al. |
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. |
2011 |
Vaccine |
pmid:21974995
|
Andrews NJ et al. |
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. |
2011 |
Vaccine |
pmid:21875635
|
Iorio AM et al. |
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. |
2012 |
Vaccine |
pmid:22245606
|
Langley JM et al. |
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. |
2012 |
Vaccine |
pmid:22469860
|
Fukase H et al. |
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. |
2012 |
Vaccine |
pmid:22472791
|
Hatz C et al. |
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. |
2012 |
Vaccine |
pmid:22446638
|
Tetsutani K and Ishii KJ |
Adjuvants in influenza vaccines. |
2012 |
Vaccine |
pmid:23084848
|
Van Buynder PG et al. |
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. |
2013 |
Vaccine |
pmid:23933368
|
Vinay TN et al. |
Inactivated vaccine against viral hemorrhagic septicemia (VHS) emulsified with squalene and aluminum hydroxide adjuvant provides long term protection in olive flounder (Paralichthys olivaceus). |
2013 |
Vaccine |
pmid:23896420
|
Poder A et al. |
An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age. |
2014 |
Vaccine |
pmid:24252703
|
Vinay TN et al. |
Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus). |
2014 |
Vet. Immunol. Immunopathol. |
pmid:23570990
|
Drulak MW et al. |
Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin. |
2000 |
Viral Immunol. |
pmid:10733168
|
Marshall BC and Adler SP |
Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). |
2003 |
Viral Immunol. |
pmid:14733736
|
Heinemann L et al. |
Effective induction of type 1 helper IgG2a and cytotoxic T-cell responses in mice following immunization with human papillomavirus type 16 E2 in MF59. |
2008 |
Viral Immunol. |
pmid:18476769
|
Burke B et al. |
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. |
2009 |
Virology |
pmid:19249806
|
Stephenson I et al. |
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. |
2004 |
Virus Res. |
pmid:15163495
|
Clouse SD |
Brassinosteroids. Plant counterparts to animal steroid hormones? |
2002 |
Vitam. Horm. |
pmid:12481548
|
Zadák Z et al. |
[The role of cholesterol and intermediary metabolites of its synthesis in intensive care and parenteral nutrition]. |
2000 |
Vnitr Lek |
pmid:15637893
|
PokrovskiÄ AA et al. |
[Method of isolating, identifying and quantitatively determining alkanes, cycloalkanes, monocyclic arenes and squalene in animal organs and tissues]. |
1978 Sep-Oct |
Vopr Pitan |
pmid:716335
|
Markelova VF and Levachev MM |
[Inclusion of C14-acetate in cholesterol and tissue squalene of rats in choline-protein deficiency]. |
1967 Nov-Dec |
Vopr Pitan |
pmid:5610866
|
Gonor KV et al. |
[The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:17313043
|
Gonor KV et al. |
[The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:16862949
|
Kulakova SN et al. |
[Amaranths oil: peculiarities of chemical composition and influence on lipid metabolism by rats]. |
2006 |
Vopr Pitan |
pmid:16862953
|
Palamarchuk VI et al. |
[Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia]. |
1983 May-Jun |
Vopr. Med. Khim. |
pmid:6880121
|
Kozlov VG and Viktorova EG |
[Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera]. |
2011 Mar-Apr |
Vopr. Virusol. |
pmid:21545042
|
Zhao M et al. |
[Research progress on the squalene synthase]. |
2003 |
Wei Sheng Wu Xue Bao |
pmid:16281569
|
Lynen F |
[The biochemical basis of the biosynthesis of cholesterol and fatty acids]. |
1966 |
Wien. Klin. Wochenschr. |
pmid:4296920
|
Bakalar B et al. |
Changes in cholesterol and its precursors during the first days after major trauma. |
2003 |
Wien. Klin. Wochenschr. |
pmid:14743581
|
|
Global Advisory Committee on Vaccine Safety, 6-7 June 2006. |
2006 |
Wkly. Epidemiol. Rec. |
pmid:16841398
|
Richter E et al. |
Stimulation of the faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in rats by squalane. |
1983 |
Xenobiotica |
pmid:6415933
|
Hu JJ et al. |
[Antibody production and its neutralization of Abeta42's cytoxicity in BALB/c mice induced by Abeta42 and its subunit vaccines]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15191720
|
Ikekawa T et al. |
[Studies on antitumor activity of squalene and its related compounds]. |
1986 |
Yakugaku Zasshi |
pmid:3772729
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Abe I |
[Engineering of squalene cyclizing enzymes]. |
2008 |
Yakugaku Zasshi |
pmid:18670176
|
Zhang Y et al. |
[Chemical constituents from the mangrove plant Ceriops tagal]. |
2005 |
Yao Xue Xue Bao |
pmid:16408813
|
Sondergaard E et al. |
Alimentary production of gallstones in hamsters. 28. Influence of isomerized squalene on gallstone production. |
1974 |
Z Ernahrungswiss |
pmid:4450595
|
Dam H et al. |
Alimentary production of gallstones in hamsters. 27. Influence of supplementation of the gallstone producing diet with squalene, cholesterol, certain other sterols, fish oil fatty acid ethyl esters, and modification of the basal diet on gallstone production and levels of cholesterol in serum and liver. |
1974 |
Z Ernahrungswiss |
pmid:4615449
|
Kipping D |
[Observations on skin surface fats]. |
1965 |
Z Haut Geschlechtskr |
pmid:5860995
|
Gloor M |
[The significance of physiological and biochemical deviations from the norm on the skin surface for infectious skin diseases (proceedings)]. |
1976 |
Z. Hautkr. |
pmid:13544
|
de la Puerta R et al. |
Effect of minor components of virgin olive oil on topical antiinflammatory assays. |
2000 Sep-Oct |
Z. Naturforsch., C, J. Biosci. |
pmid:11098836
|
Kopena R et al. |
Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. |
2009 May-Jun |
Z. Naturforsch., C, J. Biosci. |
pmid:19678551
|
Liu Y et al. |
[Researches on influence of squalene synthase gene polymorphism on catalytic efficiency of its encode enzyme in Glycyrrhiza uralensis]. |
2012 |
Zhongguo Zhong Yao Za Zhi |
pmid:23627178
|
Li RC et al. |
[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly]. |
2008 |
Zhonghua Liu Xing Bing Xue Za Zhi |
pmid:19040034
|